Scott R. Berry

Association Between Prognosis and Tumor Laterality in Early-Stage Colon Cancer

Safiya Karim, Kelly Brennan, Sulaiman Nanji et al. · JAMA Oncology · 2017 · 101 citations · Full text

Medicine, Cancer Biology, Oncology +12

Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis

Kelvin Chan, Helen Guo, Sierra Cheng et al. · Cancer Medicine · 2019 · 91 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

RiseTx: testing the feasibility of a web application for reducing sedentary behavior among prostate cancer survivors receiving androgen deprivation therapy

Linda Trinh, Kelly P. Arbour‐Nicitopoulos, Catherine M. Sabiston et al. · International Journal of Behavioral Nutrition and Physical Activity · 2018 · 78 citations · Full text

Education, Health Behavior, Oncology +17

Continental Divide? The Attitudes of US and Canadian Oncologists on the Costs, Cost-Effectiveness, and Health Policies Associated With New Cancer Drugs

Scott R. Berry, Chaim M. Bell, Peter A. Ubel et al. · Journal of Clinical Oncology · 2010 · 77 citations · Full text

Public Affairs, Health Policy, Oncology +17

CCTG CO.26 trial: A phase II randomized study of durvalumab (D) plus tremelimumab (T) and best supportive care (BSC) versus BSC alone in patients (pts) with advanced refractory colorectal carcinoma (rCRC).

Eric Xueyu Chen, Derek J. Jonker, Hagen F. Kennecke et al. · Journal of Clinical Oncology · 2019 · 40 citations

Medicine, Oncology, Pharmacology +17